Author

C. Boyer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:drug response / drug discovery· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Organism:bacteria (other)· 1

Frequent Co-Authors

C. Kopecky· 2 shared D. Goldstein· 2 shared E. Gonzales-Aloy· 2 shared E. Pandzic· 2 shared G. Sharbeen· 2 shared J. A. McCarroll· 2 shared J. Kokkinos· 2 shared J. Youkhana· 2 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Kopecky

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

A phylogenetic host range index reveals contrasted relationships between phage virulence and specialisation

C. Torres-Barcelo, C. Boyer, J. Garneau, S. Poussier, I. Robene, B. Moury

This study introduces a phylogenetic host range index to classify phages as specialists or generalists and examines the relationship between phage virulence and host range across different epidemiological contexts.

bioRxiv · May 7, 2024 · PreprintMicrobiology

Microencapsulation of mesenchymal stromal cells in covalent alginate hydrogels for cell therapy

M. Ambrosino, F. Nativel, C. Boyer, N. Lagneau, F. Loll, B. Halgand, F. Djouad, D. Renard, A. Tessier, J. Guicheux, V. Delplace, C. Le Visage

This study develops covalent alginate hydrogels using SPAAC cross-linking for encapsulating human adipose MSCs, demonstrating their viability and immunomodulatory activity in vitro.

bioRxiv · Nov 27, 2023 · PreprintBioengineering

A synthetic peptide mimic kills Candida albicans and synergistically prevents infection

S. Schaefer, R. Vij, J. L. Sprague, S. Austermeier, H. Dinh, P. R. Judzewitsch, E. Seemann, B. Qualmann, A. K. Cain, N. Corrigan, M. S. Gresnigt, C. Boyer, M. D. Lenardon, S. Brunke

This study identifies synthetic peptide mimics that kill Candida albicans and synergize with caspofungin to prevent infection, showing efficacy in vitro and in vivo without resistance development.

bioRxiv · Sep 25, 2023Microbiology

βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer

J. Kokkinos, G. Sharbeen, R. M. C. Ignacio, E. Pandzic, J. Youkhana, C. Boyer, K. S. Haghighi, M. Gunawarman, D. Goldstein, V. Gebski, M. Pajic, O. Pitiyarachchi, M. E. Davis, G. Schulstad, O. S. M. Arkell, , P. A. Phillips

This study identifies βIII-tubulin as a suppressor of extrinsic apoptosis in pancreatic cancer, showing that its silencing enhances sensitivity to death signals and reduces tumor progression.

bioRxiv · Sep 29, 2022 · PreprintCancer Biology

Bringing the pancreas patient back to the bench: Ex vivo culture of intact human patient derived pancreatic tumour tissue

J. Kokkinos, G. Sharbeen, K. S. Haghighi, R. M. C. Ignacio, C. Kopecky, E. Gonzales-Aloy, J. Youkhana, E. Pandzic, C. Boyer, T. P. Davis, L. M. Butler, D. Goldstein, J. A. McCarroll, P. A. Phillips

This paper develops an ex vivo explant model of human pancreatic tumour tissue that maintains 3D architecture and microenvironmental cues, enabling study of PDAC biology and therapeutic response.

bioRxiv · Jul 30, 2020Cancer Biology